TY  - JOUR

T1  - Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine

JO  - Cancer Management and Research

PY  - 2015/08/25

AU  - Mandrik O

AU  - Corro Ramos I

AU  - Knies S

AU  - Al M

AU  - Severens JH

ED  - 

DO  - DOI: 10.2147/cmar.s79258

PB  - Informa UK Limited

SP  - 279

EP  - 279

Y2  - 2025/04/05

ER  -